The effects of cabergoline in reducing the size of endometrioma
Phase 3
Recruiting
- Conditions
- Endometriosis of ovary.Endometriosis of ovary
- Registration Number
- IRCT20150817023666N9
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 32
Inclusion Criteria
one-sided endometrioma
Size less than 5 cm
No ultrasound criteria for malignancy
The absence of laboratory criteria for malignancy
Have informed consent to enter the study
Maximum 45 years
Exclusion Criteria
Hormonal treatment includes Contraceptive 3 months before entering the study
Cabergolin sensitivity
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome: 25% reduction in endometrium size. Timepoint: Treatment is done for 12 weeks for intervention and control groups. Method of measurement: The results of ultrasound.
- Secondary Outcome Measures
Name Time Method